clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Combining Blood Test with Clinical Score Offers Breakthrough for Stroke Detection
News & Features
New Protein Marker Identified for Breast Cancer Prognosis
Molecular Dx
Cord Blood Proteomic Profile May Help Predict Baby Growth Trajectories
News & Features
AI Could Automate Oropharyngeal Cancer Staging
News & Features
Can New Biomarker Data Improve Cardiovascular Risk Assessment?
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Strata, UCSF Collaborate to Advance Precision Medicine in Prostate Cancer
Anti cancer drugs
News & Features
Strata, UCSF Collaborate to Advance Precision Medicine in Prostate Cancer
Inside Precision Medicine Staff Writer
-
October 3, 2017
0
Molecular Dx
Janssen Biotech to Use Adaptive’s clonoSEQ Assay in Darzalex Myeloma Trials
Inside Precision Medicine Staff Writer
-
June 21, 2017
0
Molecular Dx
Thermo Fisher to Develop NGS-based CDx for Agios’ Cancer Candidate
Inside Precision Medicine Staff Writer
-
May 18, 2017
0
Molecular Dx
Myriad to Develop CDx for BeiGene’s PARP Inhibitor BGB-290
Inside Precision Medicine Staff Writer
-
April 6, 2017
0
Molecular Dx
Loxo Oncology, Ventana in CDx Development Collaboration for Cancer Candidate Larotrectinib
Inside Precision Medicine Staff Writer
-
March 20, 2017
0
Informatics
In Silico Insights: Harnessing Bioinformatics to Find New Breast Cancer Drug Combinations
Diana Kwon
-
February 7, 2017
0
Molecular Dx
Strata Oncology to Offer Patient ID and Enrollment for Epizyme Trial of NHL Candidate
Inside Precision Medicine Staff Writer
-
February 6, 2017
0
Molecular Dx
GenomeDx Tests, Database to Help Astellas Identify Patients for Prostate Cancer Drug Xtandi
Inside Precision Medicine Staff Writer
-
February 1, 2017
0
Molecular Dx
Researchers Link Effect of Cancer Drug With Alzheimer’s-Protecting Mutation
Inside Precision Medicine Staff Writer
-
January 24, 2017
0
Molecular Dx
New Sequencing Technique for Cisplatin Damaged DNA Unveiled
Inside Precision Medicine Staff Writer
-
October 24, 2016
0
1
...
19
20
21
Page 20 of 21
Related Content
Patients Aged 80 to 90 Respond to Standard-of-Care AML Treatment
Sylvester Cancer Center Launches Precision-Medicine Focused Brain Tumor Institute
Studies Find Blood Proteins That May Predict Cancer Seven Years before It Is Diagnosed
Intense Ultrasound Releases Cancer Biomarkers, Allows for Earlier Cancer Detection
Inside Precision Medicine
![Companies will use clonSEQ Assay for measuring minimal residual disease in multiple myeloma patients who have been treated with Darzalex. [iStock/©dmbaker]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1138.jpeg "Janssen Biotech to Use Adaptive’s clonoSEQ Assay in Darzalex Myeloma Trials")
